Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model
F1000Research · 12.02.2024 · 12 · 1224
DOI: 10.12688/f1000research.139482.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 12.02.2024. Verfasst von Max J Cumberland und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England, B15 2TT, UK. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Cardiac, Tissue Engineering, Fibroblasts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for the Replacement, Refinement and Reduction of Animals in Research, British Heart Foundation, Medical Research Council.
Abstract (Originalsprache)
Animal models have proven integral to broadening our understanding of complex cardiac diseases but have been hampered by significant species-dependent differences in cellular physiology. Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have shown great promise in the modelling of cardiac diseases despite limitations in functional and structural maturity. 3D stem cell-derived cardiac models represent a step towards mimicking the intricate microenvironment present in the heart as an in vitro model. Incorporation of non-myocyte cell types, such as cardiac fibroblasts, into engineered heart tissue models (EHTs) can help better recapitulate the cell-to-cell and cell-to-matrix interactions present in the human myocardium. Integration of human-induced pluripotent stem cell-derived cardiac fibroblasts (hiPSC-CFs) and hiPSC-CM into EHT models enables the generation of a genetically homogeneous modelling system capable of exploring the abstruse structural and electrophysiological interplay present in cardiac pathophysiology. Furthermore, the construction of more physiologically relevant 3D cardiac models offers great potential in the replacement of animals in heart disease research. Here we describe efficient and reproducible protocols for the differentiation of hiPSC-CMs and hiPSC-CFs and their subsequent assimilation into EHTs. The resultant EHT consists of longitudinally arranged iPSC-CMs, incorporated alongside hiPSC-CFs. EHTs with both hiPSC-CMs and hiPSC-CFs exhibit slower beating frequencies and enhanced contractile force compared to those composed of hiPSC-CMs alone. The modified protocol may help better characterise the interplay between different cell types in the myocardium and their contribution to structural remodelling and cardiac fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England, B15 2TT, UK.
- Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham, England, B15 2TT, UK.
- Biodiscovery Institute, University of Nottingham, Nottingham, England, NG7 2RD, UK.
- Department of Cardiology, University Heart and Vascular Center Hamburg, Universitat Hamburg, Hamburg, Hamburg, 20251, Germany.
- Institute of Clinical Sciences, University of Birmingham, Birmingham, England, B15 2TT, UK.
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, England, OX3 9DU, UK.
ORCID-Profile: Max J Cumberland, Jonas Euchner, Amar J Azad, Katja Gehmlich
Förderung
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
- British Heart Foundation
- Medical Research Council
- Academy of Medical Sciences
- Fondation Leducq
- Deutsche Forschungsgemeinschaft
- National Centre for the Replacement Refinement and Reduction of Animals in Research
- MAESTRIA
Zitieren
APA
Cumberland, M. J., Euchner, J., Azad, A. J., T N Vo, N., Kirchhof, P., Holmes, A. P., Denning, C., & Gehmlich, K. (2024). Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model. F1000Research, 12, 1224. https://doi.org/10.12688/f1000research.139482.2
Vancouver
Cumberland MJ, Euchner J, Azad AJ, T N Vo N, Kirchhof P, Holmes AP, et al. Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model. F1000Research. 2024;12:1224. doi:10.12688/f1000research.139482.2
BibTeX
@article{Cumberland2024,
author = {Cumberland, Max J and Euchner, Jonas and Azad, Amar J and T N Vo, Nguyen and Kirchhof, Paulus and Holmes, Andrew P and Denning, Chris and Gehmlich, Katja},
title = {Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model},
journal = {F1000Research},
year = {2024},
volume = {12},
pages = {1224},
doi = {10.12688/f1000research.139482.2}
}
EUVIMED